Similar articles

• A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

  Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL; South African Intrapartum Nevirapine Trial (SAINT) Investigators. Moodley D, et al. J Infect Dis. 2003 Mar 1;187(5):725-35. doi: 10.1086/367898. Epub 2003 Feb 24. J Infect Dis. 2003. PMID: 12599045 Clinical Trial.
• Global strategies for the prevention of HIV transmission from mothers to infants: the second conference.

  MacDougall DS. MacDougall DS. J Int Assoc Physicians AIDS Care. 1999 Dec;5(12):52-7, 62. J Int Assoc Physicians AIDS Care. 1999. PMID: 11367349
• Unequal care sustains vertical transmission rate.

  Kasper T. Kasper T. GMHC Treat Issues. 1999 Feb;13(2):11-2. GMHC Treat Issues. 1999. PMID: 11366115
• International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.

  Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N. Dao H, et al. Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S42-55. doi: 10.1016/j.ajog.2007.03.001. Am J Obstet Gynecol. 2007. PMID: 17825650 Review.
• HIV: mother to child transmission.

  Volmink J. Volmink J. Clin Evid. 2003 Jun;(9):785-94. Clin Evid. 2003. Update in: Clin Evid. 2004 Jun;(11):902-12. PMID: 12967392 Updated. Review. No abstract available.